Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection

European Journal of Immunology

Volumn 45, Issue 1, 2015, Pages 130-141

  Edwards, Chelsea L ^a   Best, Shannon E ^a   Gun, Sin Yee ^b,c   Claser, Carla ^b   James, Kylie R ^a,d   de Oca, Marcela Montes ^a,d   Sebina, Ismail ^a,d   Rivera, Fabian de Labastida ^a   Amante, Fiona H ^a   Hertzog, Paul J ^e   Engwerda, Christian R ^a   Renia, Laurent ^b,c   Haque, Ashraful ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b AGENCY FOR SCIENCE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Cytokines; Immune regulation; Interferons; Malaria; T helper cells

Indexed keywords

INTERFERON; INTERFERON REGULATORY FACTOR 7; ALPHA BETA INTERFERON RECEPTOR; IFNAR1 PROTEIN, MOUSE; IRF7 PROTEIN, MOUSE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOACCUMULATION; BRAIN MALARIA; CONTROLLED STUDY; FATALITY; FEMALE; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION SENSITIVITY; MOUSE; NONHUMAN; PARASITE CONTROL; PARASITE IMMUNITY; PARASITEMIA; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPATIOTEMPORAL ANALYSIS; TH1 CELL; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN; C57BL MOUSE; DISEASE PREDISPOSITION; DRUG EFFECTS; ERYTHROCYTE; GENE EXPRESSION REGULATION; GENETICS; HOST PARASITE INTERACTION; IMMUNOLOGY; MALARIA; PARASITOLOGY; PLASMODIUM BERGHEI; SPLEEN; TIME;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; DISEASE SUSCEPTIBILITY; ERYTHROCYTES; FEMALE; GENE EXPRESSION REGULATION; HOST-PARASITE INTERACTIONS; INTERFERON REGULATORY FACTOR-7; MALARIA, CEREBRAL; MICE; MICE, INBRED C57BL; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; SPLEEN; TH1 CELLS; TIME FACTORS;

EID: 84920973757     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444824     Document Type: Article

References (48)

1. Isaacs, A. and Lindenmann, J., Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 1957. 147: 258-267.
2. Isaacs, A., Lindenmann, J. and Valentine, R. C., Virus interference. II. Some properties of interferon. Proc. R. Soc. Lond. B Biol. Sci. 1957. 147: 268-273.
3. Baron, S. and Buckler, C. E., Circulating interferon in mice after intravenous injection of virus. Science 1963. 141: 1061-1063.
4. Axtell, R. C., de Jong, B. A., Boniface, K., van der Voort, L. F., Bhat, R., De Sarno, P., Naves, R. et al., T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat. Med. 2010. 16: 406-412.
5. Axtell, R. C., Raman, C. and Steinman, L., Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin. Rev. Allergy Immunol. 2013. 44: 114-120.
6. de Weerd, N. A., Vivian, J. P., Nguyen, T. K., Mangan, N. E., Gould, J. A., Braniff, S. J. et al., Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1. Nat. Immunol. 2013. 14: 901-907.
7. Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T. et al., IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005. 434: 772-777.
8. Auerbuch, V., Brockstedt, D. G., Meyer-Morse, N., O'Riordan, M. and Portnoy, D. A., Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J. Exp. Med. 2004. 200: 527-533.
9. Carrero, J. A., Calderon, B. and Unanue, E. R., Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J. Exp. Med. 2004. 200: 535-540.
10. Stanley, S. A., Johndrow, J. E., Manzanillo, P. and Cox, J. S., The Type I IFN response to infection with Mycobacterium tuberculosis requires ESX-1-mediated secretion and contributes to pathogenesis. J. Immunol. 2007. 178: 3143-3152.
11. Antonelli, L. R., Gigliotti Rothfuchs, A., Goncalves, R., Roffe, E., Cheever, A. W., Bafica, A., Salazar, A. M. et al., Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population. J. Clin. Invest. 2010. 120: 1674-1682.
12. Berry, M. P., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A., Oni, T., Wilkinson, K. A. et al., An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010. 466: 973-977.
13. Desvignes, L., Wolf, A. J. and Ernst, J. D., Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. J. Immunol. 2012. 188: 6205-6215.
14. Teles, R. M., Graeber, T. G., Krutzik, S. R., Montoya, D., Schenk, M., Lee, D. J., Komisopoulou, E. et al., Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses. Science 2013. 339: 1448-1453.
15. Parker, D. and Prince, A., Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. J. Immunol. 2012. 189: 4040-4046.
16. Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C., Welch, M., Schreiber, R. D. et al., Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 2013. 340: 207-211.
17. Wilson, E. B., Yamada, D. H., Elsaesser, H., Herskovitz, J., Deng, J., Cheng, G., Aronow, B. J. et al., Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 2013. 340: 202-207.
18. Xin, L., Vargas-Inchaustegui, D. A., Raimer, S. S., Kelly, B. C., Hu, J., Zhu, L., Sun, J. et al., Type I IFN receptor regulates neutrophil functions and innate immunity to Leishmania parasites. J. Immunol. 2010. 184: 7047-7056.
19. Haque, A., Best, S. E., Ammerdorffer, A., Desbarrieres, L., de Oca, M. M., Amante, F. H., de Labastida Rivera, F. et al., Type I interferons suppress CD4 T-cell-dependent parasite control during blood-stage Plasmodium infection. Eur. J. Immunol. 2011. 41: 2688-2698.
20. Haque, A., Best, S. E., Montes de Oca, M., James, K. R., Ammerdorffer, A., Edwards, C. L., de Labastida Rivera, F. et al., Type I IFN signaling in CD8-DCs impairs Th1-dependent malaria immunity. J. Clin. Invest. 2014. 124: 2483-2496.
21. Beattie, L., Phillips, R., Brown, N., Owens, B. M., Chauhan, N., Dalton, J. E. and Kaye, P. M., Interferon regulatory factor 7 contributes to the control of Leishmania donovani in the mouse liver. Infect. Immun. 2011. 79: 1057-1066.
22. Zhou, S., Cerny, A. M., Fitzgerald, K. A., Kurt-Jones, E. A. and Finberg, R. W., Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection. J. Virol. 2012. 86: 11254-11265.
23. Salem, M., Mony, J. T., Lobner, M., Khorooshi, R. and Owens, T., Interferon regulatory factor-7 modulates experimental autoimmune encephalomyelitis in mice. J. Neuroinflamm. 2011. 8: 181.
24. Ball, E. A., Sambo, M. R., Martins, M., Trovoada, M. J., Benchimol, C., Costa, J., Antunes Goncalves, L. et al., IFNAR1 controls progression to cerebral malaria in children and CD8+ T cell brain pathology in Plasmodium berghei-infected mice. J. Immunol. 2013. 190: 5118-5127.
25. Aucan, C., Walley, A. J., Hennig, B. J., Fitness, J., Frodsham, A., Zhang, L., Kwiatkowski, D. et al., Interferon-alpha receptor-1 (IFNAR1) variants are associated with protection against cerebral malaria in the Gambia. Genes Immun. 2003. 4: 275-282.
26. Khor, C. C., Vannberg, F. O., Chapman, S. J., Walley, A., Aucan, C., Loke, H., White, N. J. et al., Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus. Genes Immun. 2007. 8: 570-576.
27. Sharma, S., DeOliveira, R. B., Kalantari, P., Parroche, P., Goutagny, N., Jiang, Z., Chan, J. et al., Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome. Immunity 2011. 35: 194-207.
28. Pamplona, A., Ferreira, A., Balla, J., Jeney, V., Balla, G., Epiphanio, S., Chora, A. et al., Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat. Med. 2007. 13: 703-710.
29. Howland, S. W., Poh, C. M., Gun, S. Y., Claser, C., Malleret, B., Shastri, N., Ginhoux, F. et al., Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria. EMBO Mol. Med. 2013. 5: 916-931.
30. Baptista, F. G., Pamplona, A., Pena, A. C., Mota, M. M., Pied, S. and Vigario, A. M., Accumulation of Plasmodium berghei-infected red blood cells in the brain is crucial for the development of cerebral malaria in mice. Infect. Immun. 2010. 78: 4033-4039.
31. Haque, A., Best, S. E., Unosson, K., Amante, F. H., de Labastida, F., Anstey, N. M., Karupiah, G. et al., Granzyme B expression by CD8+ T cells is required for the development of experimental cerebral malaria. J. Immunol. 2011. 186: 6148-6156.
32. Amante, F. H., Haque, A., Stanley, A. C., Rivera Fde, L., Randall, L. M., Wilson, Y. A., Yeo, G. et al., Immune-mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J. Immunol. 2010. 185: 3632-3642.
33. Khoury, D. S., Cromer, D., Best, S. E., James, K. R., Kim, P. S., Engwerda, C. R., Haque, A. et al., Effect of mature blood-stage Plasmodium parasite sequestration on pathogen biomass in mathematical and in vivo models of malaria. Infect. Immun. 2014. 82: 212-220.
34. Haque, A., Best, S. E., Amante, F. H., Ammerdorffer, A., de Labastida, F., Pereira, T., Ramm, G. A. et al., High parasite burdens cause liver damage in mice following Plasmodium berghei ANKA infection independently of CD8(+) T cell-mediated immune pathology. Infect. Immun. 2011. 79: 1882-1888.
35. Suss, G., Eichmann, K., Kury, E., Linke, A. and Langhorne, J., Roles of CD4- and CD8-bearing T lymphocytes in the immune response to the erythrocytic stages of Plasmodium chabaudi. Infect. Immun. 1988. 56: 3081-3088.
36. Langhorne, J., Meding, S. J., Eichmann, K. and Gillard, S. S., The response of CD4+ T cells to Plasmodium chabaudi chabaudi. Immunol. Rev. 1989. 112: 71-94.
37. Meding, S. J., Cheng, S. C., Simon-Haarhaus, B. and Langhorne, J., Role of gamma interferon during infection with Plasmodium chabaudi chabaudi. Infect. Immun. 1990. 58: 3671-3678.
38. Good, M. F., Reiman, J. M., Rodriguez, I. B., Ito, K., Yanow, S. K., El-Deeb, I. M., Batzloff, M. R. et al., Cross-species malaria immunity induced by chemically attenuated parasites. J. Clin. Invest. 2013. 123: 3353-3362.
39. deWalick, S., Amante, F. H., McSweeney, K. A., Randall, L. M., Stanley, A. C., Haque, A., Kuns, R. D, et al., Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral malaria. J. Immunol. 2007. 178: 6033-6037.
40. Kim, C. C., Nelson, C. S., Wilson, E. B., Hou, B., DeFranco, A. L. and DeRisi, J. L., Splenic red pulp macrophages produce type I interferons as early sentinels of malaria infection but are dispensable for control. PLoS One 2012. 7: e48126.
41. Hwang, S. Y., Hertzog, P. J., Holland, K. A., Sumarsono, S. H., Tymms, M. J., Hamilton, J. A., Whitty, G. et al., A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc. Natl. Acad. Sci. USA 1995. 92: 11284-11288.
42. Swann, J. B., Hayakawa, Y., Zerafa, N., Sheehan, K. C., Scott, B., Schreiber, R. D., Hertzog, P. et al., Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J. Immunol. 2007. 178: 7540-7549.
43. Amante, F. H., Stanley, A. C., Randall, L. M., Zhou, Y., Haque, A., McSweeney, K., Waters, A. P. et al., A role for natural regulatory T cells in the pathogenesis of experimental cerebral malaria. Am. J. Pathol. 2007. 171: 548-559.
44. Apte, S. H., Groves, P. L., Roddick, J. S., P. da Hora, V. and Doolan, D. L., High-throughput multi-parameter flow-cytometric analysis from micro-quantities of plasmodium-infected blood. Int. J. Parasitol. 2011. 41: 1285-1294.
45. Klonis, N., Crespo-Ortiz, M. P., Bottova, I., Abu-Bakar, N., Kenny, S., Rosenthal, P. J. and Tilley, L., Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion. Proc. Natl. Acad. Sci. USA 2011. 108: 11405-11410.
46. Malleret, B., Claser, C., Ong, A. S., Suwanarusk, R., Sriprawat, K., Howland, S. W., Russell, B. et al., A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci. Rep. 2011. 1: 118.
47. Haque, A., Best, S. E., Amante, F. H., Mustafah, S., Desbarrieres, L., de Labastida, F., Sparwasser, T. et al., CD4+ natural regulatory T cells prevent experimental cerebral malaria via CTLA-4 when expanded in vivo. PLoS Pathog. 2010. 6: e1001221.
48. Belnoue, E., Kayibanda, M., Vigario, A. M., Deschemin, J. C., van Rooijen, N., Viguier, M., Snounou, G. et al., On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J. Immunol. 2002. 169: 6369-6375.